The results showed that FOXD2-AS1 expression was significantly upregulated in 21 out of 24 tumor tissues comparing with their adjacent normal tissues (Fig. 1g, h), and ratcheted up in later stage cancer (Fig. 1i). The gene discussed is FOXD2; the disease is neoplasm.